Efficacy of Computer Controlled Intraosseous Anesthesia in Pediatric Dental Patients
Launched by ALEXANDRIA UNIVERSITY · Jan 29, 2024
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new method of pain management called intra-osseous anesthesia, which is delivered using a device called Quicksleepr5. The goal is to see if this method is more effective at eliminating pain during dental treatments, such as repairing cavities or removing teeth, in young children compared to traditional anesthesia methods.
To participate in this trial, children aged 6 to 12 who are able to cooperate during dental assessments may be eligible. They should have at least one primary molar (baby tooth) that needs either treatment or extraction. However, children with certain health issues, such as disabilities, allergies to anesthesia, or those on specific medications, will not be able to join. If enrolled, participants can expect to receive either the new anesthesia method or the standard one during their dental visit, helping researchers understand which works better for managing pain in pediatric patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Cooperative children during preoperative assessments.
- • Patients selected in the restorative group: presenting with at least one primary molar indicated for restorative treatment or vital pulp therapy, after thorough clinical and radiographic examination.
- • Patients selected in the extraction group: presenting with at least one primary molar indicated for extraction.
- Exclusion Criteria:
- • Any physical or mental disability, or psychological problems.
- • Immunocompromised patients.
- • Hypersensitivity to local anesthetic drugs used
- • History of previous dental local anesthesia.
- • Taking analgesics or other medications that would alter the child behavior or awareness of pain 12- hours pre-operative
About Alexandria University
Alexandria University, a leading academic institution in Egypt, is dedicated to advancing medical research and improving healthcare outcomes through innovative clinical trials. With a strong emphasis on collaboration and interdisciplinary approaches, the university leverages its extensive resources and expertise to conduct rigorous studies that address pressing health challenges. By fostering partnerships with healthcare professionals, industry leaders, and regulatory bodies, Alexandria University aims to contribute to the global body of medical knowledge and enhance the quality of patient care through evidence-based findings.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Alexandria, Alexandroa, Egypt
Patients applied
Trial Officials
sara quritum
Principal Investigator
Alexandria Univeristy
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported